Peer-reviewedCC BY 4.0JAMA Network Open
Comparative Safety of Overactive Bladder Treatments—Unexpected Results in Context
- 1Division of Geriatric Medicine, Queen’s University, Kingston, Ontario, Canada
- 2Providence Care Hospital, Kingston, Ontario, Canada
Related
- Comparative Neoplasm Risk of Mirabegron and Antimuscarinic Therapy in Overactive Bladder: A Multicenter Target Trial Emulation
- Oxytocin Signalling in Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia and Overactive Bladder Syndrome: A Narrative Review
- Effect of the rs12249854 Polymorphism in the HECTD2 Gene and Selected Clinical Variables on the Response to Intradetrusor Injection of Botulinum Neurotoxin Type A in Female Patients with Overactive Bladder: A Single-Center Prospective Study
- Decision-Making in Refractory Overactive Bladder: Evaluation of a Novel Patient Decision Aid and its Impact on Decisional Conflict
- Efficacy of a standardized cranberry supplement on overactive bladder symptoms and urobiome alterations in young women: a randomized, double-blind, placebo-controlled pilot trial.
BibTeX
@article{gill2026comparative,
title = {{Comparative Safety of Overactive Bladder Treatments—Unexpected Results in Context}},
author = {Sudeep S. Gill},
journal = {JAMA Network Open},
year = {2026},
month = nov,
doi = {10.1001/jamanetworkopen.2026.42034},
url = {https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2856330},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Comparative Safety of Overactive Bladder Treatments—Unexpected Results in Context
AU - Sudeep S. Gill
PY - 2026
DA - 2026/11/06
JO - JAMA Network Open
DO - 10.1001/jamanetworkopen.2026.42034
UR - https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2856330
SN - 2574-3805
ER -